Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 222

1.

Functional polymorphisms in FAS/FASL system increase the risk of neuroblastoma in Chinese population.

Han W, Zhou Y, Zhong R, Wu C, Song R, Liu L, Zou L, Qiao Y, Zhai K, Chang J, Huang L, Liu L, Lu X, Lou J, Yu D, Tan W, Zhang J, Wang H, Miao X.

PLoS One. 2013 Aug 12;8(8):e71656. doi: 10.1371/journal.pone.0071656. eCollection 2013.

2.

Single-nucleotide gene polymorphisms involving cell death pathways: a study of Chinese patients with lumbar disc herniation.

Sun Z, Ling M, Chang Y, Huo Y, Yang G, Ji Y, Li Y.

Connect Tissue Res. 2013;54(1):55-61. doi: 10.3109/03008207.2012.734878. Epub 2012 Dec 3.

PMID:
23205884
3.

Functional polymorphisms in FAS and FASL contribute to risk of squamous cell carcinoma of the larynx and hypopharynx in a Chinese population.

Wang J, Gao J, Li Y, Zhao X, Gao W, Peng L, Yan D, Liu L, Li D, Wei L, Qi J, Zhou C.

Gene. 2013 Jul 25;524(2):193-6. doi: 10.1016/j.gene.2013.04.034. Epub 2013 Apr 22.

PMID:
23618817
4.

Quantitative assessment of the association between Fas/FasL gene polymorphism and susceptibility to esophageal carcinoma in a north Chinese population.

Zhang M, Wu C, Li B, Du W, Zhang C, Chen Z.

Cancer Med. 2016 Apr;5(4):760-6. doi: 10.1002/cam4.633. Epub 2016 Jan 27.

5.

Polymorphisms of death pathway genes FAS and FASL and risk of nasopharyngeal carcinoma.

Cao Y, Miao XP, Huang MY, Deng L, Lin DX, Zeng YX, Shao JY.

Mol Carcinog. 2010 Nov;49(11):944-50. doi: 10.1002/mc.20676.

PMID:
20842669
6.

Functional polymorphisms in cell death pathway genes FAS and FAS ligand and risk of prostate cancer in a Chinese population.

Shao P, Ding Q, Qin C, Wang M, Tang J, Zhu J, Chen J, Cao Q, Li J, Xu B, Zhang Z, Zhang W, Yin C.

Prostate. 2011 Jul;71(10):1122-30. doi: 10.1002/pros.21328. Epub 2011 Jan 12.

PMID:
21557277
7.

Genetic polymorphisms in the Fas and FasL genes are associated with epithelial ovarian cancer risk and clinical outcomes.

Li Y, Hao YL, Kang S, Zhou RM, Wang N, Qi BL.

Gynecol Oncol. 2013 Mar;128(3):584-9. doi: 10.1016/j.ygyno.2012.12.002. Epub 2012 Dec 9.

PMID:
23234803
8.

Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma.

Sun T, Miao X, Zhang X, Tan W, Xiong P, Lin D.

J Natl Cancer Inst. 2004 Jul 7;96(13):1030-6.

PMID:
15240787
9.

FAS and FAS ligand polymorphisms in the promoter regions and risk of gastric cancer in Southern China.

Wang M, Wu D, Tan M, Gong W, Xue H, Shen H, Zhang Z.

Biochem Genet. 2009 Aug;47(7-8):559-68. doi: 10.1007/s10528-009-9264-0. Epub 2009 Jun 30.

PMID:
19565204
10.

Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer.

Zhang B, Sun T, Xue L, Han X, Zhang B, Lu N, Shi Y, Tan W, Zhou Y, Zhao D, Zhang X, Guo Y, Lin D.

Carcinogenesis. 2007 May;28(5):1067-73. Epub 2006 Dec 20.

PMID:
17183065
11.

Functional variants in cell death pathway genes and risk of pancreatic cancer.

Yang M, Sun T, Wang L, Yu D, Zhang X, Miao X, Liu J, Zhao D, Li H, Tan W, Lin D.

Clin Cancer Res. 2008 May 15;14(10):3230-6. doi: 10.1158/1078-0432.CCR-08-0177.

12.

FAS -1377 G/A polymorphism and the risk of lymph node metastasis in cervical cancer.

Kang S, Dong SM, Seo SS, Kim JW, Park SY.

Cancer Genet Cytogenet. 2008 Jan 1;180(1):1-5.

PMID:
18068525
13.

Association of FAS and FAS ligand genes polymorphism and risk of systemic lupus erythematosus.

Moudi B, Salimi S, Farajian Mashhadi F, Sandoughi M, Zakeri Z.

ScientificWorldJournal. 2013 Nov 14;2013:176741. doi: 10.1155/2013/176741. eCollection 2013.

14.

[Genetic polymorphisms of apoptosis-associated genes FAS and FASL and risk of colorectal cancer].

Yang S, Miao XP, Zhang XM, Sun T, Qu SN, Xiong P, Ye YJ, Guo YL, Tan W, Wang S, Lin DX.

Zhonghua Yi Xue Za Zhi. 2005 Aug 10;85(30):2132-5. Chinese.

PMID:
16313826
15.

FasL -844T/C and Fas -1377G/A: mutations of pulmonary adenocarcinoma in South China and their clinical significances.

Zhao H, Chen W, Du P, Sun A, Zhuang C, Tong J, Wang L.

Tumour Biol. 2015 Jun;36(6):4319-26. doi: 10.1007/s13277-015-3071-5. Epub 2015 Jan 18.

16.

[Relationship between FAS/FASL gene polymorphisms and susceptibility of coal worker's pneumoconiosis].

Ni CH, Song ZF, Jia XM, Li AP, Li CP, Li SK, Li YM, Wang ZL, Zhou Y, Wang SY, Zhang ZD, Zhou JW.

Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2007 Sep;25(9):532-6. Chinese.

PMID:
17997887
17.

Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer.

Zhang X, Miao X, Sun T, Tan W, Qu S, Xiong P, Zhou Y, Lin D.

J Med Genet. 2005 Jun;42(6):479-84.

18.

Polymorphisms of death pathway genes FAS and FASL and risk of premalignant gastric lesions.

Hsu PI, Lu PJ, Wang EM, Ger LP, Lo GH, Tsay FW, Chen TA, Yang HB, Chen HC, Lin WS, Lai KH.

Anticancer Res. 2008 Jan-Feb;28(1A):97-103.

19.

Polymorphisms in promoter region of FAS and FASL gene and risk of cardia gastric adenocarcinoma.

Zhou RM, Wang N, Chen ZF, Duan YN, Sun DL, Li Y.

J Gastroenterol Hepatol. 2010 Mar;25(3):555-61. doi: 10.1111/j.1440-1746.2009.06116.x. Epub 2010 Jan 13.

PMID:
20074157
20.

Genetic polymorphisms of FAS and FASL (CD95/CD95L) genes in cervical carcinogenesis: An analysis of haplotype and gene-gene interaction.

Lai HC, Lin WY, Lin YW, Chang CC, Yu MH, Chen CC, Chu TY.

Gynecol Oncol. 2005 Oct;99(1):113-8.

PMID:
15996722

Supplemental Content

Support Center